Effects of Aspirin on Platelet-Neutrophil Interactions
- 1 April 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 91 (7) , 2080-2088
- https://doi.org/10.1161/01.cir.91.7.2080
Abstract
Background In recent studies, the hypothesis has been raised that the mechanisms by which aspirin acts as a protective anti-ischemic agent exceed the inhibition of platelet thromboxane A 2 synthesis. Recently, new data have been obtained disclosing a platelet-antiaggregating effect by neutrophils, which occurs through a nitric oxide (NO)/cGMP-dependent pathway. Methods and Results The present study, using platelets and neutrophils from normal subjects, was undertaken to assess the putative effect of aspirin on the neutrophil-mediated, platelet-inactivating effect. Aspirin facilitated the inhibitory effect of neutrophils on platelet activation by thrombin, ADP, or epinephrine. This effect was equally evident in vitro and in blood samples of normal individuals taking aspirin. A significant stimulation of NO-mediated mechanisms in the presence of aspirin was disclosed by different methods, as follows: (1) the increased metabolism of arginine to citrulline, (2) the increase of cGMP in the platelet/neutrophil system, and (3) the inhibitory action of the l -arginine (L-Arg)–competitive analogue L-NMMA, which was reversed by L-Arg. The effect of aspirin appeared to be related to cyclooxygenase inhibition, since it was reproduced by using indomethacin. The vasoconstricting peptide endothelin-1 (ET-1) reversed the effect of aspirin through the endogenous production of platelet-activating factor (PAF) by neutrophils, as judged by the marked inhibitory effect of the PAF antagonist BN-52021. Conclusions Our results show that a significant part of the effect of aspirin on platelet activation involves a neutrophil-mediated, NO/cGMP-dependent mechanism. The presence of ET-1 counterbalances these effects of neutrophils on platelet activation, therefore acting as an indirect proactivating agent. These results add new elements for interpreting the effects of aspirin on the interactions between blood cells, with special reference to high endothelin states (for example, ischemia/reperfusion processes).Keywords
This publication has 41 references indexed in Scilit:
- Effects of Nitric Oxide on Red Blood Cells: Changes in Erythrocyte Resistance to Hypotonic Hemolysis and Potassium Efflux by Experimental Maneuvers That Decrease Nitric OxideBiochemical and Biophysical Research Communications, 1994
- Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins.Journal of Clinical Investigation, 1993
- Inhibition by L-arginine of the endothelin-mediated increase in cytosolic calcium in human neutrophilsBiochemical and Biophysical Research Communications, 1991
- The Current Role of Platelet-Active Drugs in Ischaemic Heart DiseaseDrugs, 1991
- Renal effects and mesangial cell contraction induced by endothelin are mediated by PAFKidney International, 1991
- Endothelin-1 enhances superoxide generation of human neutrophils stimulated by the chemotactic peptide n-formyl-methionyl-leucyl-phenylalanineBiochemical and Biophysical Research Communications, 1990
- Endothelial, platelet and leukocyte interactions in ischemic heart disease: Insights into potential mechanisms and their clinical relevanceJournal of the American College of Cardiology, 1990
- Dose-Related Kinetics of AspirinNew England Journal of Medicine, 1984
- Presence of platelet-activating factor in blood from humans and experimental animals. Its absence in anephric individualsBiochemical and Biophysical Research Communications, 1984
- Pharmacokinetics of Acetylsalicylic Acid and Salicylic Acid After Intravenous Administration in ManJournal of Pharmaceutical Sciences, 1968